, Tracking Stock Market Picks
Enter Symbol:
Alexion Pharmaceuticals, Inc. (ALXN) [hlAlert]

Neutral ALXN

Alexion Pharmaceuticals, Inc. (ALXN) rated Neutral with price target $76 by Robert W. Baird

Posted on: Friday,  Nov 12, 2010  8:25 AM ET by Robert W. Baird

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)
rated Neutral with price target $76 by Robert W. Baird.

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system induces undesired inflammation in the human body. These candidates are designed to block components of the human immune system which cause undesired inflammation while allowing beneficial components of the immune system to remain functional.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2012 8:25 AM Buy
81.51 100.00
as of 8/27/2015
1 Week down  -5.16 %
1 Month down  -5.81 %
3 Months up  11.21 %
1 YTD up  35.32 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/12/2010 8:25 AM Hold
17.97 19.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy